Future Trends in Alzheimers, Dementia and Parkinson's Disease

Future Trends in Alzheimers, Dementia and Parkinson's Disease is organized by eMedEvents.

Neurological disorders are mostly considered as one of the most common disorders that are a high burden to the patients, their families, and society. However, researchers and healthcare practitioners are focussing on disease prevention, prolonging life and promoting health and well-being through organized community effort.  

In 2019 a report released by World Alzheimer Report shows that around 50 million people worldwide were reported to be suffering from Alzheimer's and related dementia, and this number is further expected to reach 152 million by 2050.

According to a market research conducted by the company Mordor Intelligence in 2020, the Alzheimer’s disease diagnostics and therapeutics market was valued at USD 6,632.82 million, and for the forecast period, 2021-2026, it is expected to reach approximately USD 9,073 million in 2026, registering a CAGR of nearly 5.36%.

Chronic diseases like alzhiemer’s, dementia and Parkinson’s disease are the prime factors in the  growth of this market increasing and the demand of drug development,  spend on biomarker drug development and increasing diagnostics for early detection.

Who should Attend?
Healthcare professionals, neuroscience researchers, neurologists, neurosurgeons, neurochemistry researchers, principal investigators, experts from universities, institutes and labs, healthcare industries, students and medical enthusiasts.

Why to Attend?
This webinar also helps to Explore the implications of a changing health system on Neurovascular diseases prevention and control as well as New innovations in Neuro research and technology.

Webinar Sessions:
• Session : Hypertension and Alzheimer's disease
• Session : Recent Evidence of Clinical Trials for Alzheimer’s Disease and New Development Strategies
• Session : Dysautonomia in Alzheimer's Disease
• Session: Preclinical Alzheimer's Disease
• Session: Dementia due to Alzheimer's Disease
• Session : Clinical Neurophysiology and Dementia
• Session : Neuroimaging in Dementia
• Session : Young onset Dementia
• Session : Translational research for Parkinson?s disease
• Session : Parkinson disease-associated cognitive impairment